Impact of Immune-based Therapies - Great impact on lymphoid malignancies
00:00:46

Impact of Immune-based Therapies - Great impact on lymphoid malignancies

Ruben Mesa, MD from UT Health San Antonio Cancer Center discusses impact of immune-based therapies and great impact on lymphoid malignancies at the 2017 American Society of Hematology.

212 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Trending

CLL Treatment Combinations for Optimal Effects
00:04:30

CLL Treatment Combinations for Optimal Effects
438 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
What are the benefits of robotic surgery over open surgery for urological cancers?
00:03:52

What are the benefits of robotic surgery over open surgery for urological cancers?
862 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
In Remembrance Of Martin Gore
00:01:12

In Remembrance Of Martin Gore
30 Views
7 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EHA 2016: A new form of inherited thrombocytopenia: ETV6, never judge a book by its cover
00:03:46

EHA 2016: A new form of inherited thrombocytopenia: ETV6, never judge a book by its cover
453 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Ovarian cancer is targetable with PARP inhibitors #SGOMTG
00:00:46

Ovarian cancer is targetable with PARP inhibitors #SGOMTG
534 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mucositis workshop highlights Paolo Bossi, MD of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy discusses a MASCC 2016 workshop focused on mucositis management. The pre-clin...
00:02:28

Mucositis workshop highlights Paolo Bossi, MD of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy discusses a MASCC 2016 workshop focused on mucositis management. The pre-clin...
176 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Therapeutically targeting mutations in myeloma: NF-?B, t(4;14) and BRAF
00:02:58

Therapeutically targeting mutations in myeloma: NF-?B, t(4;14) and BRAF
123 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Abstract Overview: Dosing of Pembrolizumab in NSCLC
00:02:27

Abstract Overview: Dosing of Pembrolizumab in NSCLC
722 Views
2 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IMpower133: Is there Finally a New Standard of Care for Extensive Stage SCLC? (BMIC-064)
00:07:18

IMpower133: Is there Finally a New Standard of Care for Extensive Stage SCLC? (BMIC-064)
333 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Anti-VEGF Therapy Has Been Standard | Field is Changing Dramatically
00:00:52

Anti-VEGF Therapy Has Been Standard | Field is Changing Dramatically
630 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Primary and secondary endpoints of the RECOURSE trial for which TAS-102 was approved at Annual Meeting GI 2016
00:01:30

Primary and secondary endpoints of the RECOURSE trial for which TAS-102 was approved at Annual Meeting GI 2016
215 Views
3 years ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Targeting sonic hedgehog signaling in AML
00:03:13

Targeting sonic hedgehog signaling in AML
531 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Investigational Melanoma Vaccine, Seviprotimut-L: Moving Forward
0:02:04

Investigational Melanoma Vaccine, Seviprotimut-L: Moving Forward
2 Views
12 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Publication in Nature Communications Confirms DRD2 as Target of ONC201

Publication in Nature Communications Confirms DRD2 as Target of ONC201
3 Views
18 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
2 Views
19 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
An Advocates Perspective to Increasing Funding Resources
0:12:29

An Advocates Perspective to Increasing Funding Resources
38 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
0:04:12

Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
11 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits

Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits
3 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Lymphoblastic Leukemia

Melanoma Rates Decline Found in Younger Population
0:03:21

Melanoma Rates Decline Found in Younger Population
1 Views
5 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias

Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
7 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
EE:EE:EE

What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
36 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit
20 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona

IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona
32 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IPS based approach for treating virus-induced tumors

IPS based approach for treating virus-induced tumors
12 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Myelogenous Leukemia

Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment

Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment
14 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How to Manage MDS Patients who are Ineligible for Transplant
00:01:47

How to Manage MDS Patients who are Ineligible for Transplant
298 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Recent Wave of Approval in AML
00:01:54

The Recent Wave of Approval in AML
137 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updated Data on Gilteritinib in AML
00:01:12

Updated Data on Gilteritinib in AML
15 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Latest Data on Uproleselan with Chemotherapy
00:01:16

Latest Data on Uproleselan with Chemotherapy
98 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
AML Case: A 54-year-old woman is in remission but MRD+
00:19:28

AML Case: A 54-year-old woman is in remission but MRD+
114 Views
5 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bladder Cancer

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
0:02:13

EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
13 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
EV-103 Phase I Trial Presented at #ESMO19
0:01:45

EV-103 Phase I Trial Presented at #ESMO19
21 Views
1 month ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer
30 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer
22 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Strategies for Treating 2nd Line RCC Patients
00:01:17

Strategies for Treating 2nd Line RCC Patients
54 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating Newly Diagnosed RCC Patients
00:02:08

Treating Newly Diagnosed RCC Patients
53 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bone Metastases

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
00:00:40

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
193 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Brain Cancer

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published

Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
2 Views
19 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence: How Does This Help Us?
0:03:05

Predicting Tumor Recurrence: How Does This Help Us?
4 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predicting Tumor Recurrence
0:03:36

Predicting Tumor Recurrence
17 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How does this affect clinicians today?
0:01:20

How does this affect clinicians today?
6 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
0:01:26

Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
14 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncoceutics Commemorates National Childhood Cancer Awareness Month

Oncoceutics Commemorates National Childhood Cancer Awareness Month
14 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Breast Cancer

Who is Eligible for the AVIATOR Study? @SeattleCCA
0:02:08

Who is Eligible for the AVIATOR Study? @SeattleCCA
2 Views
6 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The AVIATOR Study @SeattleCCA
0:04:33

The AVIATOR Study @SeattleCCA
2 Views
6 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer

Roswell Park Breast Surgery Chief Gives Keynote Talk on Immunotherapy for Breast Cancer
7 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Biomarkers with Locally Advanced Metastatic Carcinoma Results
0:03:52

Biomarkers with Locally Advanced Metastatic Carcinoma Results
3 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Biomarkers in Urothelial Carcinoma
0:03:25

Biomarkers in Urothelial Carcinoma
30 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Trends in Breast Cancer Death Rates
0:03:03

Trends in Breast Cancer Death Rates
2 Views
4 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login